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Abstract Using the principle of 
under-water-seal pressure, we 
assembled a circuit to produce an 
effective Bubble Continuous Posi-
tive Airway Pressure device at the 
National Hospital. The device is 
reasonably inexpensive and is suit-
able for use at secondary and terti-
ary health institutions for the care 
of the preterm infant with RDS.  
Introduction  
 
Prematurity is a major cause of neonatal deaths in devel-
oping Countries.1-2 It accounts for 25% of neonatal 
deaths in Nigeria.3 Respiratory distress resulting from 
surfactant deficiency accounts for a significant propor-
tion of deaths among preterm babies globally.4 Invasive 
respiratory support is fraught with several short and long 
term complications including pneumothorax and bro-
chopulmonary dysplasia5 Its application is capital inten-
sive and also requires specialized technical support 
which limits its use in most resource poor countries.  
Prematurity is a major cause of neonatal deaths particu-
larly in developing countries.1-2,3 A significant propor-
tion of preterm deaths worldwide are caused by respira-
tory illnesses requiring assisted ventilation.4 Tradition-
ally, respiratory support is invasive and is fraught with 
several short and long term complications including 
pneumothorax and brochopulmonary dysplasia.5 Its ap-
plication is capital intensive and also requires special-
ized technical support which limits its use in most  
resource poor countries. There is currently, a global shift 
towards the use of non invasive respiratory support for 
preterm babies with RDS, the hallmark of which is the
application of continuous positive airway pressure 
(CPAP). 6-7 The benefits of CPAP in the management of 
respiratory distress syndrome are well documented8-10. 
 
Different devices are used for the delivery of CPAP in-
cluding conventional ventilators, variable-flow infant 
CPAP and the Bubble CPAP. The essential components 
of a CPAP device include apressure generator, the 
CPAP circuit and airway interface.11 Bubble CPAP has 
an edge over the others because it is cheap and easy to 
apply. Its superiority over ventilator-derived CPAP in 
the management of preterm infants with RDS was dem-
onstrated by Bahman-Bijari et al12. In Bubble CPAP, an 
oscillatory pressure is generated by the flow of gas 
through an under-water seal system. In addition to the 
pressure generated, mechanical vibrations similar to 
those of high frequency ventilation are transmitted o the 
chest. 
 
Commercially available Bubble CPAP devices are quite 
expensive and most health institutions in resource con-
strained countries may not be able to afford them. The
effectiveness of locally adapted Bubble CPAP devices 
has been documented14. To meet the increasing demand 
for a simple respiratory support for preterm babies in 
our institution, we modified the existing Bubble CPAP 
devise using readily available but far less expensive  
materials. The resultant product is cheap, easily asem-
bled and can be applied by both doctors and nurses aft r 
a short training. The aim of this initial communicat on is 
to describe the devise which can be used in both ter iary 
and secondary health institutions in the management of 
RDS with the ultimate goal of reducing neonatal  




Materials and Methods  
 
The infant oxygen delivery tubes with binasal prongs 
(manufactured by Jiangsu Yada Technology Group Co 
Ltd China, fig 1) essentially serve as the CPAP  
circuit, providing the inspiratory limb, the interface 
(nasal prongs) and the proximal part of the expiratory  
limb. The proximal end of the inspiratory limb connects 
the humidified oxygen source (oxygen cylinder, oxygen 
concentrator or wall-piped oxygen) through the interface 
to the baby. It is interesting to note that these tubes are 
available in most tertiary institutions where they are 
traditionally used to deliver intranasal oxygen to infants 
in the neonatal and paediatric wards. 
 
Fig 1: CPAP circuit (oxygen delivery tube) 
The nasal prong (which is a component of the oxygen 
delivery tube) comes in different sizes. It is firmly ap-
plied to the nostrils by gently adjusting the strap around 
the baby’s head. These prongs are soft and therefor d  
not cause pressure induced ischaemic damage to the 
nasal septum as reported with the nasal prongs that 
come with commercially available CPAP devices. The 
CPAP generator is a cylindrical, transparent bottle fill d 
to predetermined level with distilled water. The expira-
tory limb of the circuit is immersed in this bottle and the 
depth of immersion in centimeters below the water  
surface corresponds to the desired CPAP in cmH20.  
The tube is carefully secured with an adhesive plaster to  
ensure that the length immersed in water remains  
constant. Figs 2 and 3 show the assembled device.  
 
Fig 2: Components of the bubble cpap device 
 
 
Fig 3: Shows the set –up of the bubble cpap 
With the oxygen flow rate set at 6-8l/min and the expira-
tory limb of the tube immersed to a depth of 5cm, bub-
bles are immediately generated. Chest auscultation is 
essential to confirm presence of bubbling sounds; its 
absence may suggest a leak along the tubing or at the 
interface (nasal prongs) or that the baby's mouth is open  
The initial response includes a significant improvement 
in the SPO2 and a noticeable reduction in the baby’s 
work of breathing. It is important to pass a nasogatric 
tube for intermittent gastric decompression to take care 
of attendant gaseous distension.  
This has been in use since November 2011 in the new-
born unit of our hospital for preterm babies with respira-
tory distress syndrome. A total of 89 babies most of 
whom were preterm, very low birth weight with respira-







This is a simple and easily affordable technology that 
promises to save the lives of preterm babies with the 
ultimate goal of reducing neonatal mortality in our s b-
region. The average cost of the disposable components 
of the device is N2, 000 ($12). The average cost of pr -
viding the consumables for the nasal flow CPAP 
(corrugated tubes, nasal prongs, head caps) is about N8, 
000($48=) per patient. Another major advantage of our 
devise is that the nasal prongs are soft and do not cause 
ischaemic damage to the nasal septum.  
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